Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4

Journal of Infectious Diseases

Volumn 200, Issue 9, 2009, Pages 1443-1451

  Yuan, Lijuan ^a,b   Honma, Shinjiro ^a,c   Kim, Inyoung ^a   Kapikian, Albert Z ^b   Hoshino, Yasutaka ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NONSTRUCTURAL VIRUS PROTEIN 4; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS PROTEIN 4; VIRUS PROTEIN 7;

ADULT; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; CASE REPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; GENOTYPE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CAPSID PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; YOUNG ADULT;

EID: 72849107610     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/606116     Document Type: Article

References (43)

1. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-295
2. Parashar UD, Burton A, Lanata C, et al. World Health Organization estimates of the global mortality from rotavirus in children in the year 2004. J Infect Dis 2009 (in press).
3. Estes MK. Rotaviruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol 2. Philadelphia: Lippincott-Raven & Wilkins, 2001:1747-1786
4. Solberg OD, Hasing ME, Trueba G, Eisenberg JN. Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus. Virology 2009; 385:58-67.
5. Matthijnssens J, Ciarlet M, Rahman M, et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol 2008; 153:1621-1629
6. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56. (Pubitemid 40070041)
7. Grimwood K, Lund JC, Coulson BS, Hudson IL, Bishop RF, Barnes GL. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J Clin Microbiol 1988; 26:732-738 (Pubitemid 18087202)
8. Weitkamp JH, Kallewaard N, Kusuhara K, et al. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J Immunol 2003; 171:4680-4688 (Pubitemid 37310585)
9. Ray PG, Kelkar SD. Measurement of antirotavirus IgM/IgA/IgG responses in the serum samples of Indian children following rotavirus diarrhoea and their mothers. J Med Virol 2004; 72:416-423
10. 0. Matsumoto M, Funami K, Tanabe M, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154-3162 (Pubitemid 37093540)
11. Velázquez FR, Matson DO, Guerrero ML, et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis 2000; 182:1602-1609
12. Eichelberger MC, Sperber E, Wagner M, et al. Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa × UK (P1A[8],G6) and Wa × (DS-1 × UK) (P1A[8],G2). J Med Virol 2002; 66:407-416 (Pubitemid 34111784) (Pubitemid 34111784)
13. Gorrell RJ, Bishop RF. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children. J Med Virol 1999; 57:204-211
14. Kapikian AZ, Wyatt RG, Levine MM, et al. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis 1983; 147:95-106.
15. Menchaca G, Padilla-Noriega L, Méndez-Toss M, et al. Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Clin Diagn Lab Immunol 1998; 5:328-334 (Pubitemid 28246455)
16. Ward RL, Knowlton DR, Schiff GM, Hoshino Y, Greenberg HB. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol 1988; 62: 1543-1549 (Pubitemid 18133171)
17. Ward RL, McNeal MM, Sander DS, Greenberg HB, Bernstein DI. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J Virol 1993; 67:464-468
18. Shaw RD, Fong KJ, Losonsky GA, et al. Epitope-specific immune responses to rotavirus vaccination. Gastroenterology 1987; 93:941-950
19. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis 1990; 161:667-679 (Pubitemid 20120223)
20. Green KY, Kapikian AZ. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol 1992; 66:548-553
21. Taniguchi K, Urasawa T, Kobayashi N, et al. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. J Clin Microbiol 1991; 29:483-487
22. Matson DO, ORyan ML, Pickering LK, et al. Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol 1992; 30:1056-1061
23. ORyan ML, Matson DO, Estes MK, Pickering LK. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis 1994; 169:504-511 (Pubitemid 24062990)
24. Colomina J, Gil MT, Codoner P, Buesa J. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection. J Med Virol 1998; 56: 58-65. (Pubitemid 28380431) (Pubitemid 28380431)
25. Richardson SC, Grimwood K, Bishop RF. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. J Clin Microbiol 1993; 31:377-385 (Pubitemid 23028644)
26. Ward RL, Bernstein DI, Shukla R, et al. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis 1989; 159:79-88. (Pubitemid 19021998)
27. Ray P, Malik J, Singh RK, et al. Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children. J Infect Dis 2003; 187:1786-1793 (Pubitemid 36667890) (Pubitemid 36667890)
28. Vizzi E, Calviño E, González R, et al. Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection. Clin Diagn Lab Immunol 2005; 12:1157-1163 (Pubitemid 41475823) (Pubitemid 41475823)
29. Yuan L, Ishida SI, Honma S, et al. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines. J Infect Dis 2004; 189:1833-1845
30. 0. Yuan L, Honma S, Ishida S, Yan XY, Kapikian AZ, Hoshino Y. Species-specific but not genotype-specific primary and secondary isotype-specific NSP4 antibody responses in gnotobiotic calves and piglets infected with homologous host bovine (NSP4[A]) or porcine (NSP4[B]) rotavirus. Virology 2004; 330:92-104. (Pubitemid 39446570)
31. Ishida S, Feng N, Tang B, Gilbert JM, Greenberg HB. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol 1996; 34:1694-1700 (Pubitemid 26190400)
32. Cao D, Igboeli B, Yuan L, et al. A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assays. Arch Virol 2009; 154:755-763
33. Efron B, Tibshirani RJ. An introduction to the bootstrap (monographs on statistics and applied probability). New York: Chapman & Hall, 1993.
34. Kirkwood CD, Gentsch JR, Hoshino Y, Clark HF, Glass RI. Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States. Virology 1999; 256:45-53.
35. Clements-Mann ML, Makhene MK, Mrukowicz J, et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine 1999; 17:2715-2725
36. Kapikian AZ, Simonsen L, Vesikari T, et al. A hexavalent human rotavirusbovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis 2005; 192(Suppl 1):S22-9
37. Heaton PM, Goveia MG, Miller JM, Offit P, Clark HF. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 2005; 192(Suppl 1):S17-21. (Pubitemid 41193097) (Pubitemid 41193097)
38. De Vos B, Han HH, Bouckenooghe A, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009; 28:261-266
39. Hoshino Y, Kapikian AZ. Rotavirus antigens. Curr Top Microbiol Immunol 1994; 185:179-227.
40. Snodgrass DR, Fitzgerald TA, Campbell I, et al. Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. J Clin Microbiol 1991; 29:2668-2672
41. Hoshino Y, Jones RW, Ross J, Kapikian AZ. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization. Vaccine 2005; 23:3791-3799 (Pubitemid 40704742)
42. Blutt SE, Conner ME. Rotavirus: to the gut and beyond! Curr Opin Gastroenterol 2007; 23:39-43.
43. Ramig RF. Systemic rotavirus infection. Expert Rev Anti Infect Ther 2007; 5:591-612